Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

As Calls For Patent Sharing To Fight Pandemic Intensify, Manufacturing May Be Bigger Issue

Apr 19 2020

• By Brenda Sandburg

Patent Health Care Pharmaceuticals Innovation concept. — Groups want biopharma companies to share their intellectual property for COVID-19 battle

Related Content

COVID-19 Partnerships Without Formal Contracts Pose Risks, From Potential Liability To IP Issues

Apr 03 2020

COVID-19: WHO Supports Pooling Of Rights, MPP Includes Drugs and Tests

Apr 07 2020

NIH Partnership To Pick COVID-19 Therapeutics For Clinical Trials; Results Anticipated By Summer

Apr 19 2020

Countries Consider Pandemic Pooling of Rights And Compulsory Licensing

Mar 26 2020

Coronavirus Update: R&D Starts, Product Delays, Continuing Collaboration

Mar 30 2020

Gilead's Request To Revoke Remdesivir Orphan Designation Reflects Pandemic Pressures

Mar 26 2020

Global IP Battle: Drug Pricing, Reimbursement Policies Take Center Stage

May 10 2018

COVID-19 Vaccine Could Cost As Little As $10 A Dose, Says Janssen

Apr 02 2020

Coronavirus Update: Sanofi And GSK Unveil 'Unprecedented' Vaccine Alliance

Apr 14 2020

Related Companies

Medtronic plc

AbbVie Inc.

Bayer AG

Gilead Sciences, Inc.

GSK plc

Sanofi

Johnson & Johnson

Additional Topics

Coronavirus COVID-19 Intellectual Property Legal Issues Policy Manufacturing BioPharmaceutical

More from Legal & IP

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window